Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Supportive Care in Cancer
Published in: Supportive Care in Cancer 10/2006

01-10-2006 | Supportive Care International

Bringing palliative care to a Canadian cancer center: the palliative care program at Princess Margaret Hospital

Authors: Camilla Zimmermann, Dori Seccareccia, Allyson Clarke, David Warr, Gary Rodin

Published in: Supportive Care in Cancer | Issue 10/2006

Login to get access

Abstract

It is increasingly recognized that complete care of the patient with cancer includes palliative care, which is applicable early in the course of illness, in conjunction with life-prolonging treatment. Princess Margaret Hospital (PMH) is Canada’s largest center for cancer care and research, and it is an international referral center for patients with cancer. The Palliative Care Program at PMH has developed into a comprehensive clinical, educational, and research program, with an acute palliative care unit, daily palliative care clinics, a cancer pain clinic, and a consultation service that sees urgent consultations on a same-day basis in inpatient and outpatient areas. We will describe the components, successes, and challenges of our program, which may be useful for others, who are developing palliative care programs in an academic setting.
Literature
1.
Addington-Hall J, McCarthy M (1995) Dying from cancer: results of a national population-based investigation. Palliat Med 9(4):295–305PubMedCrossRef
2.
3.
Bruera E, Sweeney C (2001) The development of palliative care at the University of Texas M.D. Anderson Cancer Center. Support Care Cancer 9(5):330–334PubMedCrossRef
4.
Bruera E, Kuehn N, Miller MJ et al (1991) The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients. J Palliat Care 7(2):6–9PubMed
5.
Bruera E, Neumann C, Brenneis C, Quan H (2000) Frequency of symptom distress and poor prognostic indicators in palliative cancer patients admitted to a tertiary palliative care unit, hospices, and acute care hospitals. J Palliat Care 16(3):16–21PubMed
6.
Bruera E, Michaud M, Vigano A et al (2001) Multidisciplinary symptom control clinic in a cancer center: a retrospective study. Support Care Cancer 9(3):162–168PubMedCrossRef
7.
Curtis EB, Krech R, Walsh TD (1991) Common symptoms in patients with advanced cancer. J Palliat Care 7(2):25–29PubMed
8.
Elsayem A, Swint K, Fisch MJ et al (2004) Palliative care inpatient service in a comprehensive cancer center: clinical and financial outcomes. J Clin Oncol 22(10):2008–20141PubMedCrossRef
9.
10.
Goldstein P, Walsh D, Horvitz LU (1996) The Cleveland Clinic Foundation Harry R. Horvitz Palliative Care Center. Support Care Cancer 4(5):329–333PubMedCrossRef
11.
Haddad P, Wong RK, Pond GR et al (2005) Factors influencing the use of single vs multiple fractions of palliative radiotherapy for bone metastases: a 5-year review. Clin Oncol (R Coll Radiol) 17(6):430–434
12.
Heyland DK, Lavery JV, Tranmer JE et al (2000) Dying in Canada: is it an institutionalized, technologically supported experience? J Palliat Care 16(Suppl):S10–S16PubMed
13.
Jones JM, Huggins MA, Rydall AC, Rodin GM (2003) Symptomatic distress, hopelessness, and the desire for hastened death in hospitalized cancer patients. J Psychosom Res 55(5):411–418PubMedCrossRef
14.
Jordhoy MS, Fayers P, Loge JH et al (2001) Quality of life in advanced cancer patients: the impact of sociodemographic and medical characteristics. Br J Cancer 85(10):1478–1485PubMedCrossRef
15.
McCarthy EP, Phillips RS, Zhong Z et al (2000) Dying with cancer: patients' function, symptoms, and care preferences as death approaches. J Am Geriatr Soc 48(5 Suppl):S110–S121PubMed
16.
National Cancer Institute of Canada (2005) Canadian Cancer Statistics 2005, Toronto, Canada
17.
[No authors listed] (1998) Cancer care during the last phase of life. J Clin Oncol 16(5):1986–1996
18.
Strasser F, Sweeney C, Willey J et al (2004) Impact of a half-day multidisciplinary symptom control and palliative care outpatient clinic in a comprehensive cancer center on recommendations, symptom intensity, and patient satisfaction: a retrospective descriptive study. J Pain Symptom Manage 27(6):481–491PubMedCrossRef
19.
von Gunten CF (2002) Secondary and tertiary palliative care in US hospitals. JAMA 287(7):875–881CrossRef
20.
Whelan TJ, Mohide EA, Willan AR et al (1997) The supportive care needs of newly diagnosed cancer patients attending a regional cancer center. Cancer 80(8):1518–1524PubMedCrossRef
21.
22.
Zhukovsky DS (2000) A model of palliative care: the palliative medicine program of the Cleveland Clinic Foundation. A World Health Organization Demonstrations Project. Support Care Cancer 8(4):268–277PubMed
23.
Zimmermann C, Rodin G (2004) The denial of death thesis: sociological critique and implications for palliative care. Palliat Med 18(2):121–128PubMedCrossRef
Metadata
Title
Bringing palliative care to a Canadian cancer center: the palliative care program at Princess Margaret Hospital
Authors
Camilla Zimmermann
Dori Seccareccia
Allyson Clarke
David Warr
Gary Rodin
Publication date
01-10-2006
Publisher
Springer-Verlag
Published in
Supportive Care in Cancer / Issue 10/2006
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-006-0093-y

Other articles of this Issue 10/2006

Supportive Care in Cancer 10/2006 Go to the issue

Original Article

Ways of understanding the encounter with head and neck cancer patients in the hospital dental team—a phenomenographic study

Original Article

A comparative study of living conditions in cancer patients who have returned to work after curative treatment

Original Article

Clinical and economic impact of epoetin in adjuvant-chemotherapy for breast cancer

Society News

Multinational Association of Supportive Care in Cancer

Review Article

Prognostic factors in patients with recently diagnosed incurable cancer: a systematic review

Special Article

The clinical significance of quality of life assessments in oncology: a summary for clinicians
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits